{"title":"Formulation and Characterization of Tranylcypromine loaded\nPolymeric Micellar In-Situ Nasal Gel for treatment of Depression","authors":"","doi":"10.46243/jst.2020.v5.i4.pp149-165","DOIUrl":null,"url":null,"abstract":":Tranylcypromine is a drug used as antidepressant,anxiolytic, nonselective MAO A/B inhibitor. This drug\nis used to treat depression.The research was conducted to develop a polymeric micelle using a block copolymer,\nPluronic F-68 and Gelucire 50/13 to improve the permeability of Tranylcypromine (TCP). A direct dissolution\nmethod was used to prepare polymeric micelles. The prepared micelles were characterised for particle size, % EE,\nzeta potential, in-vitro release. These micelles solution was used to prepare in situ gel by cold method in order to\nachieve controlled release. Central composite design was used for optimization of both polymeric micelles and insitu nasal gel.The main objective of this research work is to develop formulation acting centrally without\nundergoing first pass metabolism i.ie. directly nasal to brain delivery route.","PeriodicalId":23534,"journal":{"name":"Volume 5, Issue 4","volume":"76 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Volume 5, Issue 4","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46243/jst.2020.v5.i4.pp149-165","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
:Tranylcypromine is a drug used as antidepressant,anxiolytic, nonselective MAO A/B inhibitor. This drug
is used to treat depression.The research was conducted to develop a polymeric micelle using a block copolymer,
Pluronic F-68 and Gelucire 50/13 to improve the permeability of Tranylcypromine (TCP). A direct dissolution
method was used to prepare polymeric micelles. The prepared micelles were characterised for particle size, % EE,
zeta potential, in-vitro release. These micelles solution was used to prepare in situ gel by cold method in order to
achieve controlled release. Central composite design was used for optimization of both polymeric micelles and insitu nasal gel.The main objective of this research work is to develop formulation acting centrally without
undergoing first pass metabolism i.ie. directly nasal to brain delivery route.